MedPath

A study to assess the effect of Yava Mantha as a pathya in the management of Prameha (Type 2 Diabetes mellitus).

Phase 2
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2023/10/058187
Lead Sponsor
Sane Guruji Arogya Kendra
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

A known Type -2 Diabetes Mellitus patient on treatment from 6 months

showing symptoms of Prameha.

Patient with fasting blood sugar >126 mg/dl -180mg/dl and post prandial blood

sugar 200-250 mg/dl

Patient having HbA1C >6.4mg/dl

Exclusion Criteria

Diabetes Mellitus Type-I and those who are under insulin therapy.

Pregnant and lactating mothers.

Patients with acute complications like Ketoacidosis and infections like

gangrene.

Patients with chronic complications like Nephropathy, Neuropathy and

Retinopathy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A clinical study to evaluate the effect of Yava Mantha in Prameha. <br/ ><br>The parameters of efficacy of Yava Mantha will be evaluate by observing the patient through subjective & objective criteria at regular intervals 0th,30th,60th,90th days follow up. The relief of sign & symptoms of Prameha will be analyzed with the help of Five point likert scale.Timepoint: The parameters of efficacy of Yava Mantha will be evaluate by observing the patient through subjective & objective criteria at regular intervals 0th,30th,60th,90th days follow up. The relief of sign & symptoms of Prameha will be analyzed with the help of Five point likert scale.
Secondary Outcome Measures
NameTimeMethod
The secondary outcome will be to explore & promote Krutanna Kalpana mention in Ayurveda Samhita.Timepoint: The Yava Mantha will be given for 90 days. Patient will be assessed on 0th,30th,60th,90th day of treatment. Total duration of study 90 days.
© Copyright 2025. All Rights Reserved by MedPath